LeMaitre Vascular, Inc. (LMAT)
81.55
-1.36
(-1.64%)
USD |
NASDAQ |
Oct 13, 16:00
81.55
0.00 (0.00%)
After-Hours: 20:00
LeMaitre Vascular Gross Profit Margin (Quarterly) : 70.12% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 70.12% |
| March 31, 2026 | 70.59% |
| December 31, 2025 | 71.66% |
| September 30, 2025 | 72.92% |
| June 30, 2025 | 67.78% |
| March 31, 2025 | 66.81% |
| December 31, 2024 | 69.26% |
| September 30, 2024 | 65.15% |
| June 30, 2024 | 66.24% |
| March 31, 2024 | 65.81% |
| December 31, 2023 | 65.01% |
| September 30, 2023 | 61.76% |
| June 30, 2023 | 61.01% |
| March 31, 2023 | 62.29% |
| December 31, 2022 | 59.87% |
| September 30, 2022 | 60.30% |
| June 30, 2022 | 62.25% |
| March 31, 2022 | 61.79% |
| December 31, 2021 | 61.86% |
| September 30, 2021 | 60.78% |
| June 30, 2021 | 61.96% |
| March 31, 2021 | 61.96% |
| December 31, 2020 | 60.64% |
| September 30, 2020 | 57.73% |
| June 30, 2020 | 64.93% |
| Date | Value |
|---|---|
| March 31, 2020 | 64.32% |
| December 31, 2019 | 63.58% |
| September 30, 2019 | 67.24% |
| June 30, 2019 | 67.02% |
| March 31, 2019 | 66.40% |
| December 31, 2018 | 65.77% |
| September 30, 2018 | 69.83% |
| June 30, 2018 | 68.76% |
| March 31, 2018 | 69.53% |
| December 31, 2017 | 68.12% |
| September 30, 2017 | 69.03% |
| June 30, 2017 | 66.24% |
| March 31, 2017 | 70.01% |
| December 31, 2016 | 67.67% |
| September 30, 2016 | 71.65% |
| June 30, 2016 | 66.83% |
| March 31, 2016 | 68.99% |
| December 31, 2015 | 68.18% |
| September 30, 2015 | 68.70% |
| June 30, 2015 | 63.80% |
| March 31, 2015 | 66.91% |
| December 31, 2014 | 66.00% |
| September 30, 2014 | 66.19% |
| June 30, 2014 | 65.94% |
| March 31, 2014 | 64.26% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Boston Scientific Corp. | 66.50% |
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 56.00% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 16.74% |
| Return on Assets | 10.73% |
| Return on Invested Capital | 11.33% |
| Profit Margin (Quarterly) | 24.22% |
| Operating Margin (Quarterly) | 28.98% |
| Return on Net Operating Assets | 27.68% |